However, with the increased popularity of GLP-1RA, the so-called Ozempic Face has emerged
While formal pharmacokinetic studies of GLP-1RA co-administration with these IBD drugs have not been conducted, clinicians should monitor for unexplained changes in therapeutic response, particularly during GLP-1RA initiation and dose escalation, and consider staggering oral medications when feasible
Common adverse effects include tachycardia, arrhythmias, and hypertension, and use is contraindicated in patients with idiopathic hypertrophic subaortic stenosis (IHSS), requiring careful monitoring during therapy
For some clients, Niagen (NR) is a preferred alternative, helping boost NAD+ levels in cells with fewer side effects and faster infusion rates than NAD+ IV Therapy